← SynDRA
NPC-15199
SynDRA canonical compound SYN1948585 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ICAM1 | PPARG |
|---|
| Mechanism of action | ICAM1 antagonist |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- 2-(9H-Fluoren-9-ylmethoxycarbonylamino)-4-methylpentanoic acid
- F-L-Leu
- CHEMBL294989
- PPARgamma Activator, Fmoc-Leu
- Fmoc-DL-leucine
- N-alpha-Fmoc-L-leucine
- NSC334290
- ACMC-209iik
- AC1L1HVH
- n-[(9h-fluoren-9-ylmethoxy)carbonyl]leucin
- ACMC-2099ky
- AC1Q5SK7
- 2-(9H-Fluoren-9-ylmethoxycarbonylamino)-4-methyl-pentanoic acid
- (2S)-2-[(fluoren-9-ylmethoxy)carbonylamino]-4-methylpentanoic acid
- GTPL2705
- SCHEMBL1002861
- CHEBI:91726
- CTK8G6077
- MolPort-003-700-319
- HMS3266H19
- SBB056939
- IN1334
- BDBM50034787
- AKOS017268980
Look up NPC-15199 in the interactive SynDRA portal →